Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence

S. Vincent Rajkumar, Robert A. Kyle, Francis K. Buadi

Research output: Contribution to journal › Comment/debate › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence'. Together they form a unique fingerprint.